Travere Therapeutics, Inc. (TVTX): Shareholders' Equity
$114.83M
As of 2025-12-31
$24.52M
As of 2026-06-30
+38.9%
3-year compound annual growth
-11.5%
5-year compound annual growth
-9.2%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $114.83M | +94.4% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $59.08M | -70.6% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $200.81M | +368.6% | 2026-02-19, Balance as of period end |
| 2022-12-31 | $42.85M | -85.8% | 2025-02-21, Balance as of period end |
| 2021-12-31 | $302.11M | +43.0% | 2024-02-20, Balance as of period end |
| 2020-12-31 | $211.21M | -4.5% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $221.20M | -30.5% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $318.25M | +8.6% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $293.13M | -4.8% | 2020-02-24, Balance as of period end |
| 2016-12-31 | $307.77M | +2.6% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $299.97M | n/m | 2018-07-06, Balance as of period end |
| 2014-12-31 | -$37.25M | n/m | 2017-03-01, Balance as of period end |
| 2013-12-31 | -$19.67M | n/m | 2016-02-26, Balance as of period end |
| 2012-12-31 | -$3.41M | n/a | 2015-07-09, Balance as of period end |
| 2012-02-29 | -$63.1K | n/a | 2012-05-24, Balance as of period end |
| 2011-12-31 | -$536.3K | n/a | 2015-07-09, Balance as of period end |
| 2011-02-28 | -$60.3K | n/a | 2012-05-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $114.83M | +94.4% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $161.55M | +0.3% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$2.09B | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $314.69M | +39.5% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $715.50M | -14.9% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.25B | +62.1% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $300.13M | +14.2% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.17B | +69.7% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $166.95M | -3.7% |
Compare TVTX, NATR, BBIO, MIRM side by side · Screen every company in Pharmaceutical Preparations ↗